About Clerio Vision
Clerio Vision is a Healthcare company based in Rochester (United States) founded in 2014. Laser induced change in refractive index. Clerio Vision has raised $28.95 million across 8 funding rounds from investors including America’s Seed Fund, National Science Foundation and UpVentures Capital. The company has 90 employees. Clerio Vision has completed 1 acquisition, including Hydrogel Vision. Its chief executive, as recorded, is Alex Zapesochny. Clerio Vision offers products and services including LIRIC Technology, Contact Lenses, Intraocular Lenses, Myopia Control, and Laser Vision Correction. Its focus areas include Life Sciences, Ophthalmology, Medical Devices and Therapy. Its legal entity is CLERIO VISION, INC. Its competitors include IntraLase, Lenticular Research Group and Summit Autonomous; 2 of its 3 listed competitors have raised funding.
Company details
Clerio Vision is developing a product for non-invasive, incision-less, tissue-sparing laser technology to modify the refractive index of the cornea and improve vision in patients with refractive errors. The procedure, called LIRIC or (laser-induced refractive index change can be used to correct both far and nearsightedness, and can also be used to adjust other more invasive treatments such as cataract or LASIK surgeries.
- Headquarters Rochester, United States
- Employees 90
- SectorsHealthcare
- Website cleriovision.com
- Social LinkedIn
- Legal Name Clerio Vision, Inc.
- Total Equity Funding$28.95M (USD)
in 8 rounds
- Latest Funding Round$8.26M (USD), Series B
Jan 2021
- InvestorsAmerica’s Seed Fund
& 2 more
- Employee Count90
- Investments & Acquisitions
Products & Services of Clerio Vision
Clerio Vision offers a comprehensive portfolio of products and services, including LIRIC Technology, Contact Lenses, Intraocular Lenses, Myopia Control, and Laser Vision Correction.
Laser-induced method for enhancing optical patterns in lenses.
Advanced lenses targeting presbyopia and other vision issues.
Lenses for correcting vision problems during eye surgeries.
Techniques to slow myopia progression in patients.
Laser-based corrections for refractive errors like astigmatism.
Funding Insights of Clerio Vision
Clerio Vision has successfully raised a total of $28.95M across 8 strategic funding rounds. The most recent funding activity was a Series B round of $8.26 million completed in January 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $28.95M
- Total Rounds 8
- Last Round Series B — $8.26M
- First Round $2M
(Jan 2015)
- Investors Count 3
All 8 funding rounds of Clerio Vision with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan 2021 | $8.26M | Series B | – | – | – |
| Jul 2019 | $11.93M | Series B | – | – | – |
| Sep 2017 | $1.25M | Grant | – | – | |
| Jul 2017 | $3.56M | Series A | – | – | – |
| Jan 2016 | $3.19M | Series A | – | – | – |
| Jan 2016 | $269,999 | Grant | – | – | |
| Jun 2015 | Seed | – | – | ||
| Jan 2015 | $2M | Seed | – | – | – |
3 investors in total: 3 institutional.
Investors in Clerio Vision
Clerio Vision has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include America’s Seed Fund, National Science Foundation and UpVentures Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital fund backed by the US Government | seedfund.nsf.gov | Alexandria, United States | ||
Investments are made in technology startups by UpVentures Capital. | upventures.com | New York, United States | ||
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Clerio Vision
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Clerio Vision
19 people are tracked at Clerio Vision (11 in leadership, 1 in board & advisors, 7 in team); the tracked headcount is 90.
| Name | Role | Group |
|---|---|---|
Alex Zapesochny | CEO | Leadership |
Filipp Ignatovich | VP of IOL Product Development | Leadership |
Ian Kelsey ASQ CRE | Director of Quality and Regulatory | Leadership |
Amanda Marie Proctor | Executive Assistant to the Vice President | Leadership |
Lisen Xu | VP, Applied Research | Leadership |
Sasha Latypova | Co-Founder, Executive vice President and Director | Leadership |
Mike Claus | Director, Systems and Software Development | Leadership |
Anna Schreyer | Executive Vice President Development Operations | Leadership |
Edie Catlin | Executive Vice President, People and Administration | Leadership |
Alissa Seidman | Executive Vice President Of Finance | Leadership |
David Mullaney | Vice President, Technical and Engineering Services | Leadership |
Mikael Totterman | Founder, Chairman Of The Board And Chief Innovation Officer | Board & advisors |
Zachary Parlet | Senior Software Developer | Team |
Angela Stetson | Manufacturing Quality Engineer | Team |
Sebastian Ferlo | Laser Research Specialist And Project Manager | Team |
Derek Sleve | Purchasing Manager | Team |
Geoff Rehberg | Research Technician/Laser Operator | Team |
Binay Pandey | System Engineer | Team |
Sam Butler | Senior Systems Engineer | Team |
Complete people profiles for Clerio Vision
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Clerio Vision
Clerio Vision has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Hydrogel Vision.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Personalized contact lenses are developed using ultra-hydrating materials. | hydrogelvision.com | Sarasota, United States | 1998 | Jul 2019 | •••• |
Complete acquisition details for Clerio Vision
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Clerio Vision
4 dated milestones of Clerio Vision across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Clerio Vision is founded.
- Funding First funding round of $2.0M.
- Acquisition Acquires Hydrogel Vision.
- Funding Latest funding round, Series B, of $8.3M.
Competitors of Clerio Vision
Clerio Vision has 3 listed competitors in our database, 2 of them funded. They include IntraLase, Lenticular Research Group and Summit Autonomous.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| intralase.com | 1997 | Irvine, United States | $29.5M | Femtosecond laser technology is developed for eye surgery procedures. | ||
| lenticularresearchgroup.com | 2007 | Naperville, United States | $330,000 | Developer of laser device for treating the cause of presbyopia | ||
| summit-autonomous.com | 1985 | Waltham, United States | Excimer laser systems are developed for correcting vision disorders. |
Detailed competitors of Clerio Vision
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Clerio Vision
The website of Clerio Vision (cleriovision.com) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 3.3% vs previous month
Top companies in Ophthalmology
3 companies that operate in the same segment as Clerio Vision (Ophthalmology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of a wide range of eye care products | 1945 | Fort Worth, Texas, United States | USD 171.61 M | USD 9.64 B | 25,600 | |
Genetic medicines are developed by 4DMT for transformative therapies. | 2013 | Emeryville, California, United States | USD 186.59 M | USD 85.21 M | 227 | |
Developer of antibodies to treat complement-mediated neurodegenerative diseases | 2011 | San Francisco, California, United States | USD 256 M | 100 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Clerio Vision
Complete news archive for Clerio Vision
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clerio Vision
Clerio Vision was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Clerio Vision is headquartered in Rochester, United States.
Alex Zapesochny is the CEO of Clerio Vision, as recorded in our data.
Clerio Vision is a funded company, having raised a total of $28.95M across 8 funding rounds to date. The company's 1st funding round was a Seed of $2M, raised on Jan 2015.
Clerio Vision has 90 employees.
Clerio Vision is developing a product for non-invasive, incision-less, tissue-sparing laser technology to modify the refractive index of the cornea and improve vision in patients with refractive errors. The procedure, called LIRIC or (laser-induced refractive index change can be used to correct both far and nearsightedness, and can also be used to adjust other more invasive treatments such as cataract or LASIK surgeries.
Clerio Vision's top competitors include IntraLase, Summit Autonomous and Lenticular Research Group.
Clerio Vision offers LIRIC Technology, Contact Lenses, Intraocular Lenses, Myopia Control, and Laser Vision Correction.
Clerio Vision has made 1 acquisition, including Hydrogel Vision.
Clerio Vision has 3 investors. Key investors include America’s Seed Fund, National Science Foundation, and UpVentures Capital.
Clerio Vision operates through Clerio Vision, Inc..